Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
read more
BioPharma Services USA, has been awarded a 5-year, $20 million contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA). The contract is to conduct in vivo studies of generic drug ...
read more
Wednesday, January 05, 2022
Piramal Pharma Limited’s Pharma Solutions (PPS) business, a Contract Research, Development and Manufacturing Organization (CDMO), announced that the company has made a multi-million-dollar investment to create a world-class high-throughput screening ...
read more
Thursday, December 01, 2022
WuXi STA, a subsidiary of WuXi AppTec announced the partnership with Multiply Labs (based in San Francisco, CA, USA), a robotics company that has developed industry-leading automated manufacturing systems to produce individualized drugs.
read more
Wednesday, January 15, 2020
Mereo BioPharma announced a global license agreement for the development and commercialization of navicixizumab.
read more
Tuesday, February 18, 2014
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Perceptive Informatics, the PAREXEL subsidiary that provides the Perceptive MyTrials® eClinical platform and other advanced ...
read more
Wednesday, August 12, 2015
Asterand Bioscience has announced the acquisition of AdeptBio LLC, a Memphis-based biobank organization, which specializes in procurement of human tissue specimens.
read more
Wednesday, October 16, 2019
CMAB Biopharma and BJ Bioscience announced a strategic agreement for the development and manufacturing of a Bi-functional Antibody as the first step in an exclusive collaboration.
read more
Ligand Pharmaceuticals announced the appointment of Nancy Ryan Gray, Ph.D. to the company’s Board of Directors.
read more
Wednesday, March 07, 2018
Pfizer CentreOne announced the introduction of Enviero progesterone into the API marketplace.
read more
Cancer Prevention Pharmaceuticals announced the signing of a license agreement with Mallinckrodt wherein Mallinckrodt obtained exclusive North American commercialization rights to CPP-1X/sul.
read more
Pfizer announced it will make a $465 million investment to build a sterile injectable pharmaceutical production facility in Portage, Michigan.
read more
GlaxoSmithKline’s Sligo plant will close the plant and lay off its 165 workers over the next three years.
read more
Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that synthetic recombinant proenzymes trypsinogen and chymotrypsinogen were successfully ...
read more
Wednesday, April 13, 2016
Laboratory Corporation of America Holdings® (LabCorp®) has announced that Covance Drug Development has completed an expansion of its now approximately 4,500 square meter (48,000 square foot) central laboratory in Geneva, Switzerland, the largest of ...
read more